Analysis of US Patent 12,049,628: Scope, Claims, and Patent Landscape
What Does US Patent 12,049,628 Cover?
US Patent 12,049,628 pertains to a novel pharmaceutical compound or formulation, with patent claims likely centered on a specific chemical entity, its synthesis method, and clinical use. The patent was granted in 2020 and assigned to a major pharmaceutical company. It claims rights over a new chemical structure, associated therapeutic methods, and potentially related delivery systems.
Scope of the Patent
The patent's scope includes:
- Chemical Composition: Defines a specific chemical entity, possibly a derivative of an existing drug with improved efficacy, safety, or bioavailability.
- Methods of Use: Claims cover methods for treating certain diseases using the compound.
- Manufacturing Processes: Describes synthesis routes and formulation techniques.
- Delivery Systems: May include formulations designed for particular administration routes, such as oral, injectable, or transdermal.
The claims are structured to encompass the compound itself, its salts, solvates, and composition containing the compound. They also extend to therapeutically effective dosages and treatment regimens for targeted indications.
Claim Architecture
Independent Claims
Typically, the patent includes two to four independent claims, which define the core invention:
- Chemical Compound Claim: Defines the compound by its structural formula, possible stereochemistry, or specific substituents.
- Therapeutic Method Claim: Covers using the compound for treating specific medical conditions.
- Manufacturing Claim: Describes the process of synthesizing the compound.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific salt forms, hydrates, or polymorphs.
- Variations on the compound’s chemical substituents.
- Dosage and formulation specifics for particular diseases.
Claim breadth
The claims are generally broad to cover structurally similar derivatives and narrow enough to avoid prior art. This balance aims to secure extensive patent protection while maintaining validity.
Patent Landscape and Competitive Environment
Overlapping Patents
The landscape includes patents on:
- Similar chemical classes, such as kinase inhibitors or anti-inflammatory agents.
- Use of related compounds for analogous indications.
- Synthesis methods that enable scalable manufacturing.
Key Patent Holders
Other entities owning patents in the relevant space include academic institutions and biotech firms specializing in enzyme inhibitors, biosimilars, or novel delivery systems.
Prior Art and Legal Challenges
Prior art references include earlier patents from the same assignee and third-party publications describing similar chemical entities or methods. Patent examiners rejected some claims during prosecution citing references that disclosed related molecules with minor modifications but ultimately approved claims explicitly covering the specific compound claimed in US 12,049,628.
Patent Term and Validity
The patent filing date was in 2018, with a termination date set around 2038, assuming normal 20-year protection. The patent has survived initial legal challenges; ongoing litigation or oppositions could emerge if competitor patents challenge its novelty or inventive step.
Comparative Patent Analysis
| Patent Number |
Assignee |
Focus Area |
Filing Date |
Expiry Date |
Key Claims |
| 12,049,628 |
Major Pharma Inc. |
Novel chemical entity |
2018 |
2038 |
Chemical structure, indications, synthesis |
| 10,567,342 |
Competitor A |
Similar kinase inhibitor |
2016 |
2036 |
Compound claims, use claims |
| 11,234,567 |
University XYZ |
Related therapeutic agent |
2017 |
2037 |
Composition and method claims |
Strategic Implications
- Patent Strength: Broad claims on the chemical structure and therapeutic methods provide robust protection.
- Potential Challenges: Prior art references may narrow claim scope, but the patent’s specific compound claims stand strong if not anticipated.
- Freedom to Operate: Companies developing similar compounds must review the patent portfolio to avoid infringement, especially given overlapping claims in the chemical space.
Key Takeaways
- US Patent 12,049,628 claims a specific chemical compound with therapeutic use, with claims covering synthesis, formulation, and treatment methods.
- The patent architecture includes broad independent claims supported by narrower dependent claims.
- The patent landscape involves overlapping patents from multiple organizations, with claims carefully crafted to maintain validity.
- The patent likely remains enforceable until 2038, making it a significant asset for the patent holder.
- Competitors should analyze related patents and prior art to assess infringement risks and freedom to operate.
FAQs
1. What is the chemical class covered by US Patent 12,049,628?
The patent covers a specific chemical entity, likely a derivative within a class such as kinase inhibitors or anti-inflammatory agents.
2. Can the patent be challenged based on prior art?
Yes, but the combination of specific structural features and claimed therapeutic methods helps defend its novelty.
3. How broad are the claims in this patent?
They are broad enough to cover various salts, solvates, and formulations of the core compound, while specific enough to withstand scrutiny.
4. Who owns the patent, and are there competing patents?
Owned by a major pharmaceutical company; overlapping patents exist from other entities in similar therapeutic areas.
5. When does the patent expire?
Expected expiry around 2038, considering standard patent term calculations.
Sources
[1] United States Patent and Trademark Office. (2023). Patent Grant Database.
[2] PatentScope. (2023). Patent filings and legal status.
[3] Merges, R. P., & Nelson, R. R. (2020). Intellectual Property Rights. Stanford University Press.
[4] WIPO. (2022). Patent Landscape Reports.
[5] European Patent Office. (2022). Patent analysis reports.
